Human Interferon Kills Resistant H7N9 Influenza
Explore a conference talk from ICAAC 2013 discussing the potential of human interferon alpha-n3 in combating oseltamivir-resistant H7N9 influenza. Learn about the April 2013 avian influenza A (H7N9) outbreak, its severity, and the development of drug resistance. Discover how this human interferon, already used for treating genital warts, shows promise against the virus. Delve into topics such as hemagglutinin, neuraminidase resistance, and the role of chickens in transmission. Understand the implications of this research, including interferon administration methods, potential for viral resistance, and the continued importance of flu vaccinations. Gain insights from experts Michael Schmidt and William M. Mitchell as they discuss the findings and answer audience questions about clinical trials and recombinant interferons.